Ashurst advises Asker Healthcare Group, a leading Swedish group in the healthcare sector, on the acquisition of 100% of the share capital and securities of the Finmed group from its shareholders. The transaction involves the integration of Finmed and its subsidiaries Frafito and AVF Biomedical, companies recognized for their expertise in the distribution of medical devices and innovative solutions for both public and private healthcare institutions.
The Ashurst team was led by François Hellot, partner, assisted by Isaure Sander, counsel, Louis Rainguenet, senior associate, and Victoire Gabai, associate, in the Paris corporate team.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
